Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions

Condition:   Bioequivalence Intervention:   Drug: Atorvastatin film-coated tablet 40 mg / Liprimar® film-coated tablet 40 mg Sponsors:   Pharmtechnology LLC;   ClinPharmInvest, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials